Uncategorized Archives - Page 200 of 221

FridaySep 15, 2017 9:31 am

ChineseInvestors.com, Inc. (CIIX) Sets Goal of Greater than 100% Gain in FY2018 Revenues

In FY2017, the company’s investor relations business grew 130%, and its subscriptions business rose by 57% Warren Wang, founder and chief executive officer of CIIX, sets goal of greater than 100% gain in sales in FY2018 and cost-cutting to achieve profitability Company excited about its expansion of auxiliary services into the digital currency industry; Wang says that market will offer long-term opportunities ChineseInvestors.com, Inc. (OTCQB: CIIX) recorded a skyrocketing 76% year-over-year operating revenues increase for its fiscal year ended May 31, 2017. The company’s two divisions exhibited double-digit and triple-digit growth in FY2017. The investor relations business grew 130%, while…

ThursdaySep 14, 2017 2:31 pm

InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Builds Moat around Proprietary Biosynthesis Technology

Proprietary biosynthesis process to produce cannabinoids Provisional patent application filed Cost-effective methodology to produce trace cannabinoids If you have any doubt that InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) is on the right track as it moves to protect its biosynthesis technology for cannabinoids, then a word from a famed figure may make you change your mind. Known worldwide for his investing prowess, Warren Buffett has said, “I don't want a business that's easy for competitors. I want a business with a moat around it with a very valuable castle in the middle” (http://cnw.fm/ehB50). Naturally, the Sage of Omaha was…

WednesdaySep 13, 2017 3:58 pm

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQB: LXRP) Oral CBD Product to Be Tested by the University of British Columbia

The University of British Columbia (UBC) will conduct a double-blind study of Lexaria’s TurboCBD™ oral ingestion product TurboCBD™ masks foul tastes, protects pharmaceutical ingredients during stomach passage and increases intestinal absorption by 5-10x The UBC study will include 24 volunteers and test their cognitive and cardiovascular function after single doses and after seven days of administration Traditionally, cannabidiol (CBD) is ingested via inhalation, which can harm the lungs, and many edible products contain unwanted sugars or sweeteners. Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has revolutionized oral intake with its TurboCBD™ product. Engineered to increase absorption through the intestinal tract,…

WednesdaySep 13, 2017 12:17 pm

Are Charity Organizations Turning Away Donations from Cannabis Companies?

No one can deny there’s a need for volunteers and donations when the top news of the day features one natural disaster after another. But for some business owners, like those in the highly regulated cannabis industry, it’s not that simple. Sometimes their proffered donations aren’t seen as a positive. Instead, they’re viewed as a liability, and one that many charity organizations aren’t willing to accept. In an article published Monday in Forbes, an attempt by one cannabis company to donate some of its profits to various charitable organizations is described as less than successful. “It felt like a slap…

TuesdaySep 12, 2017 3:55 pm

Algae Dynamics Corp. (ADYNF) Collaborating with Prominent Neuroscientist to Research Benefits of Cannabis Oil for Mental Health Disorders

Partnership between Algae Dynamics and Dr. Steven Laviolette focuses on medical benefits of cannabis and hemp oils for various mental health disorders Canada is moving to legalize cannabis throughout the country in 2018, which could radically change research playing field Canadian cannabis oil extraction market projected to reach $1.5 billion by 2020 Algae Dynamics Corp. (OTCQB: ADYNF), a Canadian company focused on the development of proprietary research and products derived from cannabis and hemp oils, has begun a collaborative relationship with one neuroscientist who is looking deep within the brain for answers to some of the world’s most pressing mental…

TuesdaySep 12, 2017 2:56 pm

India Globalization Capital, Inc. (NYSE: IGC) Announces Alzheimer’s Drug Candidate Targeting Aβ Proteins

More than 5.3 million people in the U.S. have Alzheimer’s disease, which has no effective cure or substantial treatment India Globalization Capital’s IGC-ADI drug candidate targets proteins associated with the buildup of lesions in the brain The company acquired exclusive rights to a patent, based on University of South Florida studies supporting THC’s role in inhibiting Aβ plaque production Alzheimer’s disease now affects over 5.3 million people in the United States, imposing an estimated economic cost of $236 billion. There has been no effective treatment to slow down or reverse its effects. That may be about to change, as India…

MondaySep 11, 2017 9:33 am

SinglePoint, Inc. (SING) Acquires Dr. FeelGood; Plans in View for Multistate Brand Expansion

SinglePoint has completed its third acquisition of 2017 Company’s revenue has grown 378-fold since first quarter 2017 Delivery application in development will directly compete with Leafly and WeedMaps Company well-positioned to continue acquisition strategy and further increase revenue Marking its third acquisition of 2017, SinglePoint, Inc. (OTC: SING) announced on September 6 that it has acquired profitable cannabis distribution company Dr. FeelGood. According to the agreement terms, SinglePoint will acquire 51 percent of the company in a combination of cash and stock, allowing SinglePoint to recognize all revenue. This acquisition adds yet another revenue stream for SinglePoint, further affirming the…

FridaySep 08, 2017 3:22 pm

ChineseInvestors.com, Inc. (CIIX) Aiming to Grow Direct-to-Consumer e-Commerce Business

Company engages Launch Haus LLC, a digital agency, to grow its direct-to-consumer e-commerce business through a new marketing campaign Consilium Global Research (http://cnw.fm/3Z9oC) projects a CAGR of nearly 100% for CIIX through FY2020, with revenues reaching $14.8 million CIIX has goal of becoming the largest Chinese publicly traded company in the legalized cannabidiol (CBD) market, with a target audience of the global Chinese-speaking community ChineseInvestors.com, Inc.’s (OTCQB: CIIX) goal of growing its global sales of hemp-based cannabidiol (CBD) products will be aided by its engagement of Launch Haus LLC, a Scottsdale, Arizona-based holding company specializing in digital direct-to-consumer marketing and…

ThursdaySep 07, 2017 2:14 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Continues Showcasing Proprietary Research at Cannabis Investment Conferences

Proprietary Lexaria technology improves delivery of bioactive compounds in a variety of products, including cannabis-based gourmet foods Market predictions for the legal marijuana industry forecast $50 billion in sales by 2026 19 patent applications filed and pending in more than 40 countries Following a successful showing at the inaugural Institutional Capital & Cannabis Conference (IC3) in California earlier this month, Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) CEO Chris Bunka expects the company to be noticed by investors. Bunka’s presentation of the company’s latest technology slated to benefit the cannabis industry includes the world’s first clinical study on human volunteers of…

WednesdaySep 06, 2017 1:42 pm

Algae Dynamics Corp. (ADYNF) Focuses on Cannabis Oil Vision for Medicinal Applications

The Canadian cannabis oil extraction market is projected to reach $1.5 billion by 2020 Algae Dynamics is focused on extracting cannabis and hemp oil, which has a range of medicinal health benefits Cannabis oil extracts act on the human endocannabinoid system, which includes receptors in the brain, organs, and tissues The oils extracted from cannabis plants, especially those with high levels of cannabidiol (CBD), have been used for medicinal purposes for millennia. Algae Dynamics Corp. (OTCQB: ADYNF) has been focused on cannabis oil extraction, part of its vision to become a world leader in this field. A $1 million market…

News and publishing service for hemp related companies

Contact us: 512.354.7000

Category: Uncategorized